Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination

Abstract

During the coronavirus disease 2019 (COVID-19) pandemic, COVID-19 vaccination-induced hyperglycemia and related complications have been reported. However, there have been few reports of type 1 diabetes triggered by COVID-19 vaccines in subjects without diabetes. Here, we report the case of a 56-year-old female patient who developed hyperglycemia after the second dose of COVID-19 mRNA-based vaccination without a prior history of diabetes. She visited our hospital with uncontrolled hyperglycemia despite administration of oral hyperglycemic agents. Her initial glycated hemoglobin level was high (11.0%), and fasting serum C-peptide level was normal. The fasting serum C-peptide level decreased to 0.269 ng/mL 5 days after admission, and the anti-glutamic acid decarboxylase antibody was positive. The patient was discharged in stable condition with insulin treatment. To our knowledge, this is the first case of the development of type 1 diabetes without diabetic ketoacidosis after mRNA-based COVID-19 vaccination, and is the oldest case of type 1 diabetes development under such circumstances.

The Impact of COVID-19 Vaccines on the Development of Acute Complications in Type 1 and 2 Diabetes Patients: A Cross-Sectional Study in the Eastern Province of Saudi Arabia

“… 13 One case of T1DM has been reported post–Moderna vaccination. 29 The present study also noted one case of T1DM after the second dose of the Moderna vaccine. A study conducted on T1DM patients who received the Moderna vaccine was reassuring, with no significant change in glycemic control.…”

Insights into new-onset autoimmune diseases after COVID-19 vaccination

“…Type 1 diabetes mellitus (T1DM) is an autoimmune endocrine disorder characterized by symptoms such as polyuria, nocturia, enuresis, lethargy, polydipsia, weight loss, and abdominal pain [ 174 ]. Out of the 13 cases analyzed (6 men and 7 women), approximately 54% did not have any medical history of autoimmune diseases, while 15% of patients had a history of vitiligo, type 2 diabetes mellitus, and Hashimoto’s thyroiditis [ [175] , [176] , [177] , [178] , [179] , [180] , [181] , [182] , [183] ]. While 10 patients received the mRNA vaccine, 2 received the inactivated vaccine.…”

SARS-CoV-2 Vaccines-Related Endocrine Disorders: An Updated Narrative Review

“…Two cases of severe diabetic ketoacidosis in patients with Type 1 diabetes mellitus were also reported after whole inactivated virus-based COVID-19 (COXAVIN) and non-replicating viral vector COVISHIELD (ChAdOx1 nCoV-19) vaccines [179]. Three more cases of Type 1 diabetes related to mRNA vaccination were recently reported [180,181]. Most of the patients who developed Type 1 diabetes after COVID-19 vaccination were discharged with permanent insulin therapy [179].…”